Moving past an anomaly: Bessemer's Andrew Hedin on 'high quality' startups driving funding in 2024
Healthcare
Stay updated with breaking news from Andrew Hedin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite artificial intelligence’s growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say it’s too early to focus on winning a race that has many twists and turns yet to come.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Plenful will use the funding to scale its team and market footprint, allowing healthcare organizations to automate tasks causing burnout.
Plenful will use the funding to scale its team and market footprint, allowing healthcare organizations to automate tasks causing burnout.